SCHEMBL5203716

SCHEMBL5203716

CC(c1ccc(Cl)cc1)C(CNC1(C(N)=O)CCCC1)c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 3/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP2D6 P10635 2/20 0.37
TACR2 P21452 1/20 0.36
TACR1 P25103 1/20 0.36
HDAC4 P56524 1/20 0.36
KMT2A Q03164 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 2/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A2 P23975 1/20 0.35
CNR1 P21554 1/20 0.35
WDR5 P61964 1/20 0.35
PRCP P42785 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5203070 0.99 TACR2 (0.38) OPRL1ALDH1A1CYP2D6TACR2TACR1
SCHEMBL5202986 0.77 KMT2A (0.40) HDAC4KMT2ASMN1; SMN2MEN1RAB9A
SCHEMBL5205537 0.75 HDAC4 (0.42) ALDH1A1HDAC4KMT2ASMN1; SMN2MEN1
SCHEMBL5200534 0.72 DRD2 (0.39) KMT2ASMN1; SMN2MEN1GAARAB9A
SCHEMBL5202845 0.72 TRPV1 (0.40) GAACNR1
SCHEMBL5205476 0.70 SLC6A2 (0.36) ALDH1A1CYP2D6KMT2AMEN1CYP2C9
SCHEMBL5266049 0.70 RAB9A (0.60) ALDH1A1KMT2ASMN1; SMN2MEN1HPGD
SCHEMBL4689271 0.69 RAB9A (0.48) ALDH1A1KMT2ASMN1; SMN2MEN1GAA
SCHEMBL5202582 0.69 MEN1 (0.38) ALDH1A1KMT2ASMN1; SMN2MEN1HPGD
SCHEMBL4694021 0.68 RAB9A (0.43) ALDH1A1KMT2ASMN1; SMN2MEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP claimed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP claimed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO claimed
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP disclosed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP disclosed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO disclosed